Sort
48,018 grants matching “immunotherapy”
Immunomodulation of breast cancer via TLR7 agonist imiquimod and radiotherapy.
$373,301Silvia C Formenti · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · CA
Core B: Clinical Core
$373,297Arthur Y Kim · Massachusetts General Hospital · U19 · FY2020 · AI
Training In Cell and Gene Therapy
$373,273Helen E Heslop · Baylor College Of Medicine · T32 · FY2022 · HL
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
$373,258Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2021 · NS
Mechanisms of Resistance to Gemtuzumab Ozogamicin
$373,230Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA
Mechanisms of Resistance to Gemtuzumab Ozogamicin
$373,230Fred Hutchinson Cancer Research Center · R01 · FY2005 · CA
Translational Research in Surgical Oncology
$373,223Herbert Kim Lyerly · Duke University · T32 · FY2019 · CA
Synergy of Radiation and Immunotherapy: New Approaches
$373,207James S. Malter · Ut Southwestern Medical Center · R01 · FY2019 · CA
INTERVENTION IN THE HYPERTROPHIC CYTOSKELETON
$373,146Columbia Univ New York Morningside · R01 · FY2002 · HL
EGFRvIII-targeted Bispecific T cell Engagers for brain tumors
$373,133John H Sampson · Duke University · R01 · FY2015 · NS
Administrative Core
$373,125James R. Heath · Institute For Systems Biology · U54 · FY2025 · CA
Amelioration of recurrent herpes keratitis
$373,095Washington University · R01 · FY2005 · EY
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
$373,072Scott I. Abrams · Roswell Park Cancer Institute Corp · R01 · FY2012 · CA
A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells
$373,068Ning Jenny Jiang · University Of Pennsylvania · R33 · FY2022 · CA
Virulence and Immunity to Staphylcocci
$373,021Brigham And Women'S Hospital · R01 · FY2003 · AI
Regulation of Death Ligand-Induced Killing
$373,020Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2015 · CA
Regulation of Death Ligand-Induced Killing
$373,020Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2016 · CA
Regulation of Death Ligand-Induced Killing
$373,020Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2017 · CA
Regulation of Death Ligand-Induced Killing
$373,020Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2018 · CA
SOUTHWEST ONCOLOGY GROUP
$373,015Wayne State University · U10 · FY2003 · CA
X-ray/optical tomographic guidance and assessment for pre-clinical radiation Research
$372,981Ken Kang-Hsin Wang · Ut Southwestern Medical Center · R37 · FY2025 · CA
Core B: Animal Model and Immunotyping Core
$372,966Thomas Alan Hamilton · Cleveland Clinic Lerner Com-Cwru · P01 · FY2024 · CA
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
$372,888Liangfang Zhang · University Of California, San Diego · R01 · FY2016 · CA
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway
$372,875Ann Richmond · Vanderbilt University · R01 · FY2015 · CA
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway
$372,875Ann Richmond · Vanderbilt University · R01 · FY2016 · CA